During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis ...

In a challenging market environment, Tilray Inc (NASDAQ:TLRY) stock has recorded a new 52-week low, dipping to $1.13.

Tilray Brands ( TLRY -11.88%) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday ...

New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...

Analyst Robert Moskow of TD Cowen maintained a Buy rating on Tilray (TLRY – Research Report), with a price target of $1.50.Stay Ahead of the ...

Beer and cannabis company's revenue falls short of analyst estimates, but one analyst says hemp-derived THC drinks may help in the future Tilray Brands Inc.'s stock fell Friday after the beer and ...

Tilray Brands (NASDAQ:TLRY) traded ~8% lower in the premarket on Friday after the Canadian cannabis company fell short of ...

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its ...

Shares of Tilray Brands Inc. TLRY shed 2.50% to $1.17 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.64% to ...

Another quarter, and another loss for Tilray Brands (TSX: TLRY) shareholders who are left wondering why they invested in the company in the first place. Investors on Friday saw the equity sink as ...